JAMA 4 2026 Real-World Outcomes of Transcatheter Tricuspid Valve Replacement Analysis From the STS/ACC TVT Registry

This study investigates the real-world safety and effectiveness of transcatheter tricuspid valve replacement (TTVR) for patients suffering from severe heart valve leakage. By analyzing data from over a thousand patients, researchers found that this minimally invasive procedure achieved a near-complete elimination of tricuspid regurgitation in the vast majority of cases. These technical successes translated into significant improvements in quality of life and physical function within just thirty days, regardless of whether patients had pre-existing heart devices. Ultimately, the findings confirm that TTVR is a reliable clinical solution for high-risk populations, mirroring the positive results of previous controlled trials with even lower rates of certain complications.